ChromaDex to Host Symposium on NAD+ in Human Health and Disease at NUTRITION 2020 LIVE ONLINE Annual Meeting
ChromaDex Corp. (NASDAQ:CDXC) announced today it has organized a virtual symposium entitled Nicotinamide Adenine Dinucleotide (NAD+) in Human Health and Disease: The State of the Science on Nutrition Interventions tomorrow Tuesday, June 2, from 8:30 to 10:00 AM EDT at NUTRITION 2020 LIVE ONLINE , the annual meeting hosted by the American Society for Nutrition (ASN).
- ChromaDex Corp. (NASDAQ:CDXC) announced today it has organized a virtual symposium entitled Nicotinamide Adenine Dinucleotide (NAD+) in Human Health and Disease: The State of the Science on Nutrition Interventions tomorrow Tuesday, June 2, from 8:30 to 10:00 AM EDT at NUTRITION 2020 LIVE ONLINE , the annual meeting hosted by the American Society for Nutrition (ASN).
- We are pleased to continue the practice of making Niagen freely available to the nutrition research community through our industry leading ChromaDex External Research Program (CERP) .
- The satellite program will focus on the latest findings on NAD+ and human health and disease and how maintaining or raising NAD+ levels contributes to resilience.
- NUTRITION 2020 LIVE ONLINE is hosted by the American Society for Nutrition (ASN), the preeminent professional organization for nutrition research scientists and clinicians around the world.